Ronald F. Feinberg: Insulin Resistance May Be an Overlooked Cardiovascular Risk Factor
Ronald F. Feinberg, Medical Advisor and Care Council Member at Fyrtle, shared a post on LinkedIn about a recent article by Henning Bundgaard et al., published in New England Journal of Medicine, adding:
”Insulin resistance: the cardiovascular (and fertility) risk factor we still don’t routinely measure?
A remarkable new New England Journal of Medicine study examined silent atherosclerosis in 16,808 adults ages 18–70.
I searched the paper for two terms:
‘Insulin’ — zero mentions.
‘Insulin resistance’ — zero mentions.
That may be as interesting to me as some of the study’s findings.
Atherosclerosis was already present in 8.7 percent of men and 6.7 percent of women ages 18–29.
By ages 30–39, it was present in 34.6 percent and 21.3 percent, respectively.
The investigators assessed BMI, blood pressure, lipids, inflammation, smoking and other conventional cardiovascular risk factors.
But apparently not insulin.
Insulin resistance is not synonymous with elevated glucose.
For years, glucose can remain normal because the pancreas compensates by producing more insulin.
I’ve spent much of my career thinking about this in PCOS/PMOS and reproductive health.
But the implications extend far beyond fertility.
This study doesn’t tell us whether hyperinsulinemia contributed to this surprisingly early atherosclerosis.
It can’t.
They didn’t measure it.
Maybe insulin would add little.
Maybe it would tell us a great deal.
But shouldn’t we know?”
Title: Prevalence of Silent Atherosclerosis across Adult Life
Authors: Henning Bundgaard, Inés García-Lunar, Klaus F. Kofoed, Rasmus Hasselbalch, Carlos Nicolás Pérez-García, Joakim Bo Kunkel, Frederik Filip Stæger, Fátima Sánchez-Cabo, José J. Fuster, Virginia Mass, Javier Sánchez-González, Maja V. Kragh, Anna K. Ringgaard, Javier Valls-Monzó, Michael Huy Cuong Pham, Ana Devesa, Morten Sejer, Per Sigvardsen, Antonio Quesada, Charlotte Eberhard, Ana García-Álvarez, Lea Marie Pehrson, Álvaro Navarro-Guzmán, Simon Winther, Mathias Sørgaard, Marcos Gámez, Martin Lundsgaard, Cristina Pérez-Herreras, Ruth Frikke-Schmidt, Pedro L. Sánchez, Nikolaj Eldrup, Juan Torres-Macho, Morten Bøttcher, Valentin Fuster, Kasper K. Iversen, Borja Ibanez
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 16:52Tosin Ola: A New Era in Sickle Cell Disease Treatment and the Question of Access
-
Oct 30, 2026, 16:48Cedric Hermans: The Next Generation of FVIIIa-Mimetic Antibodies in Haemophilia A
-
Oct 30, 2026, 16:44Shehab Mohamed: Recognizing Isolated Thrombocytopenia as a Presentation of MDS
-
Oct 30, 2026, 16:40Amrita Sarkar: Advancing the Diagnosis of Anti-PF4 Syndromes
-
Oct 30, 2026, 16:35James Garrard: Driving Innovation in Stroke Care Through Global Collaboration
-
Oct 30, 2026, 16:19Cesar de Almeida Neto: Hemo 2026 Roundtable Focuses on the Challenges of Patient Blood Management
-
Oct 30, 2026, 16:01Marilena Vrana: The Case for Retaining Immunoglobulins on the EU Critical Medicines List
-
Oct 30, 2026, 15:53Ilenia Calcaterra: Patient Blood Management Across Complex Hematological Conditions
-
Oct 30, 2026, 15:40Isabella Presch: The Practicalities of Gene Therapy Adoption in Hemophilia